DIA’s Sorcha McCrohan, contributing to the the August 2024 edition of DIA’s Global Forum magazine, reviews insights from the town hall meetings that brought together regulators from around the world at the organization’s Global Annual Meeting 2024.
Regulators worldwide recently convened in San Diego for DIA’s Global Annual Meeting 2024 to discuss respective countries’ priorities and chart new horizons in reimagining regulatory processes, alignment, and collaboration. Regulatory representation at several Town Halls included intergovernmental bodies like the World Health Organization (WHO), international coalitions such as the International Coalition of Medicines Regulatory Authorities (ICMRA), and regional agencies including the US FDA, European Medicines Agency (EMA), Health Canada, ANVISA (Brazil), PMDA (Japan), and NMPA (China). The meeting also featured the Access Consortium, a coalition of regulatory authorities from Australia, Canada, Singapore, Switzerland, and the United Kingdom.
These Town Halls exposed the heterogeneity of regional regulatory systems, supporting ongoing efforts to achieve greater regulatory harmonization. Such efforts would serve to streamline processes, reduce duplication of global health initiatives, and promote equitable access to safe and efficacious medicines worldwide.
To read the rest of the article, visit the DIA Global Forum website here
